About us
Immunotech Biopharm Ltd: (stock code: 06978.HK, referred to as " Immunotech Biopharm ") is one of the earliest enterprises in China to conduct research on individualized cellular immunotherapy products in accordance with drug registration, and is one of the earliest new drugs enterprises to apply to the National Medical Products Administration for approval for clinical trials. It is the first cellular immunotherapy company in China to be successfully listed under Chapter 18A of the Listing Rules of the Hong Kong Stock Exchange.
...
News
Patient
From November 2006 to April 2016, EAL® products have been used in clinical treatment of more than 4,000 patients in dozens of hospitals.
Recruitment
Address：8th Floor, Building 1, No. 1, Kangding Street, Beijing Economic and Technological Development Zone, Beijing
Resume delivery email：hr@eaal.net
Contact numbe：010-88400295
